Open House Drug Rebate Agreement Interferon beta-1a (Rebif), ATC L03AB07
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Interferon beta-1a, Fertigarzneimittelbezeichnung Rebif(R), ATC L03AB07
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No guaranteed volume; actual discount may be high with no return.
Contract can be superseded by future competitive contracts, leading to automatic termination.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jul 2028
- Non-exclusive rebate agreement for Interferon beta-1a (Rebif), ATC L03AB07.
- Contract duration: August 2026 to July 2028.
Show full summary
Open House (non-exclusive) rebate agreement for Interferon beta-1a (Rebif) offered by AOK Bayern. Any eligible pharmaceutical company can join by submitting required documents by monthly deadlines. The contract runs from August 2026 to July 2028. No estimated value provided.
Risks
No guaranteed volume; actual discount may be high with no return.
Contract can be superseded by future competitive contracts, leading to automatic termination.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical company.
Certifications
- Documents in German or accompanied by certified German translation.
Administrative
- Submit signed contract, signed annex specifying the medicinal products, and signed declaration of reliability.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open House Drug Rebate Agreement Interferon beta-1a (Rebif), ATC L03AB07
Non-exclusive rebate agreement for Interferon beta-1a (Rebif). Eligible pharmaceutical companies can sign identical, non-negotiable terms. Contract may be terminated if a competitive discount contract is concluded. Submission deadlines: 3rd of each month for next month start; final deadline 3 June 2028.
Location
Duration
Category
Award Criteria
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Interferon beta-1a, Fertigarzneimittelbezeichnung Rebif(R), ATC L03AB07
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Procurement Details
- Publication date
- 14 Jun 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 406578-2026
Documents (2)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No guaranteed volume; actual discount may be high with no return.
Contract can be superseded by future competitive contracts, leading to automatic termination.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications